Biomarkers S100B and neuron-specific enolase predict outcome in hypothermia-treated encephalopathic newborns

Pediatric Critical Care Medicine

Volumn 15, Issue 7, 2014, Pages 615-622

  Massaro, An N ^a,b   Chang, Taeun ^a,b,c   Baumgart, Stephen ^a,b   McCarter, Robert ^a,b,c   Nelson, Karin B ^a,b,c   Glass, Penny ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Development; Encephalopathy; Neuron specific enolase; S100B protein; Therapeutic hypothermia

Indexed keywords

NEURON SPECIFIC ENOLASE; PROTEIN S100B; BIOLOGICAL MARKER; ENOLASE; S100B PROTEIN, HUMAN;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INDUCED HYPOTHERMIA; MAJOR CLINICAL STUDY; MALE; NEONATAL ENCEPHALOPATHY; NERVE CELL DIFFERENTIATION; NEWBORN; NEWBORN DISEASE; NEWBORN MORTALITY; NEWBORN PERIOD; PRIORITY JOURNAL; SOCIOECONOMICS; TREATMENT OUTCOME; BLOOD; BRAIN DISEASES; CHILD DEVELOPMENT; COGNITION; COHORT ANALYSIS; DEVELOPMENTAL DISABILITIES; INFANT; METABOLISM; MOTOR PERFORMANCE; NEWBORN INTENSIVE CARE; PHYSIOLOGY; PREDICTIVE VALUE; PRESCHOOL CHILD;

BIOMARKERS; BRAIN DISEASES; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COGNITION; COHORT STUDIES; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; INFANT; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; MALE; MOTOR SKILLS; PHOSPHOPYRUVATE HYDRATASE; PREDICTIVE VALUE OF TESTS; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; TREATMENT OUTCOME;

EID: 84926118520     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0000000000000155     Document Type: Article

References (41)

1. Shankaran S, Woldt E, Koepke T., et al: Acute neonatal morbidity and long-term central nervous system sequelae of perinatal asphyxia in term infants. Early Hum Dev 1991; 25:135-148
2. Dilenge ME, Majnemer A, Shevell MI: Long-term developmental outcome of asphyxiated term neonates. J Child Neurol 2001; 16:781-792
3. Shankaran S, Laptook AR, Ehrenkranz R.A., et al; National Institute of Child Health and Human Development Neonatal Research Network: Whole-body hypothermia for neonates with hypoxic-ischemic enceph-alopathy. N Engl J Med 2005; 353:1574-1584
4. Gluckman PD, Wyatt JS, Azzopardi D, et al: Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: Multicentre randomised trial. Lancet 2005; 365:663-670
5. Azzopardi DV, Strohm B, Edwards A.D., et al; TOBY Study Group: Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009; 361:1349-1358
6. Jacobs SE, Morley CJ, Inder T.E., et al; Infant Cooling Evaluation Collaboration: Whole-body hypothermia for term and near-term new-borns with hypoxic-ischemic encephalopathy: A randomized controlled trial. Arch Pediatr Adolesc Med 2011; 165:692-700
7. Massaro AN, Chang T, Kadom N., et al: Biomarkers of brain injury in neonatal encephalopathy treated with hypothermia. J Pediatr 2012; 161:434-440
8. Gonçalves C.A., Leite MC, Nardin P: Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin Biochem 2008; 41:755-763
9. Michetti F, Gazzolo D: S100B protein in biological fluids: A tool for perinatal medicine. Clin Chem 2002; 48:2097-2104
10. Kaiser E, Kuzmits R, Pregant P., et al: Clinical biochemistry of neuron specific enolase. Clin Chim Acta 1989; 183:13-31
11. Sarnat HB, Sarnat MS: Neonatal encephalopathy following fet al distress. A clinical and electroencephalographic study. Arch Neurol 1976; 33:696-705
12. Bayley N: Manual for the Bayley Scales of Infant Development. New York, Psychological Corporation, 1969
13. Bayley N: Bayley Scales of Infant Development. Third Edition. San Antonio, TX, Harcourt Assessment, 2006
14. Stata-Corporation: Stata Statistical Software: Release 11. College Station, TX, StataCorp LP, 2009
15. Shankaran S, Laptook AR, Tyson J.E., et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network: Evolution of encephalopathy during whole body hypothermia for neonatal hypoxic-ischemic encephalopathy. J Pediatr 2012; 160:567.e3-572.e3
16. Holmes G, Rowe J, Hafford J., et al: Prognostic value of the electroencephalogram in neonatal asphyxia. Electroencephalogr Clin Neurophysiol 1982; 53:60-72
17. Obrecht R, Pollock MA, Evans S, et al: Prediction of outcome in neonates using EEG. Clin Electroencephalogr 1982; 13:46-49
18. Thoresen M, Hellström-Westas L, Liu X, et al: Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia. Pediatrics 2010; 126:e131-e139
19. Massaro AN, Tsuchida T, Kadom N., et al: aEEG evolution during therapeutic hypothermia and prediction of NICU outcome in encephalo-pathic neonates. Neonatology 2012; 102:197-202
20. Shankaran S, Barnes PD, Hintz S.R., et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network: Brain injury following trial of hypothermia for neonatal hypoxic-ischaemic encephalopathy. Arch Dis Child Fet al Neonatal Ed 2012; 97:F398-F404
21. Rutherford M, Ramenghi LA, Edwards A.D., et al: Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: A nested substudy of a randomised controlled trial. Lancet Neurol 2010; 9:39-45
22. Gunn AJ, Wyatt JS, Whitelaw A, et al; CoolCap Study Group: Therapeutic hypothermia changes the prognostic value of clinical evaluation of neonatal encephalopathy. J Pediatr 2008; 152:55-58, 58.e1
23. Barkovich AJ, Miller SP, Bartha A, et al: MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol 2006; 27:533-547
24. McKinstry RC, Miller JH, Snyder A.Z., et al: A prospective, longitudinal diffusion tensor imaging study of brain injury in newborns. Neurology 2002; 59:824-833
25. Berger RP, Adelson PD, Pierce M.C., et al: Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and nonin-flicted traumatic brain injury in children. J Neurosurg 2005; 103:61-68
26. Jauch EC, Lindsell C, Broderick J., et al; NINDS rt-PA Stroke Study Group: Association of serial biochemical markers with acute ischemic stroke: The National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 2006; 37:2508-2513
27. Nagdyman N, Kömen W, Ko H.K., et al: Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr Res 2001; 49:502-506
28. Nagdyman N, Grimmer I, Scholz T., et al: Predictive value of brain-specific proteins in serum for neurodevelopmental outcome after birth asphyxia. Pediatr Res 2003; 54:270-275
29. Thorngren-Jerneck K., Alling C, Herbst A., et al: S100 protein in serum as a prognostic marker for cerebral injury in term newborn infants with hypoxic ischemic encephalopathy. Pediatr Res 2004; 55:406-412
30. Celtik C, Acunaş B, Oner N, et al: Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy. Brain Dev 2004; 26:398-402
31. Douglas-Escobar M., Yang C, Bennett J., et al: A pilot study of novel biomarkers in neonates with hypoxic-ischemic encephalopathy. Pediatr Res 2010; 68:531-536
32. Massaro AN, Jeromin A, Kadom N., et al: Serum biomarkers of MRI brain injury in neonatal hypoxic ischemic encephalopathy treated with whole body hypothermia - A pilot study. Pediatr Crit Care Med 2013; 14:310-317
33. Ennen CS, Huisman TA, Savage W.J., et al: Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling. Am J Obstet Gynecol 2011; 205:251.e1-251.e7
34. Florio P, Frigiola A, Battista R., et al: Activin A in asphyxiated full-term newborns with hypoxic ischemic encephalopathy. Front Biosci (Elite Ed) 2010; 2:36-42
35. Gazzolo D, Di Iorio R, Marinoni E, et al: S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage. Crit Care Med 2002; 30:1356-1360
36. Keustermans GC, Hoeks SB, Meerding J.M., et al: Cytokine assays: An assessment of the preparation and treatment of blood and tissue samples. Methods 2013; 61:10-17
37. Berger R, Richichi R: Derivation and validation of an equation for adjustment of neuron-specific enolase concentrations in hemolyzed serum. Pediatr Crit Care Med 2009; 10:260-263
38. Haimoto H, Hosoda S, Kato K: Differential distribution of immuno-reactive S100-alpha and S100-beta proteins in normal nonnervous human tissues. Lab Invest 1987; 57:489-498
39. Marangos PJ, Campbell IC, Schmechel D.E., et al: Blood platelets contain a neuron-specific enolase subunit. J Neurochem 1980; 34:1254-1258
40. Anderson PJ, De Luca CR, Hutchinson E, et al; Victorian Infant Collaborative Group: Underestimation of developmental delay by the new Bayley-III Scale. Arch Pediatr Adolesc Med 2010; 164:352-356
41. Msall ME: Measuring outcomes after extreme prematurity with the Bayley-III Scales of infant and toddler development: A cautionary tale from Australia. Arch Pediatr Adolesc Med 2010; 164:391-393